Q1 FY27 earnings call · July 31, 2026

Aarti Industries Ltd (AARTIIND) Q1 FY27 Earnings Call: Maintains Rs.1,800 Cr EBITDA Guidance, Fuel Additives Capacity Reaches 360 KTPA

Cofacto ResearchPublished July 31, 20266 min read
Quick summary

Aarti Industries Ltd held its Q1 FY27 earnings call on July 30, 2026. Here's a quick read of what management said — performance, strategy, and the outlook ahead.

Revenue, Profit & Headline Metrics

  • Revenue grew 41% YoY to Rs.2,627 Cr in Q1 FY 2026-2027; EBITDA rose 79% YoY to Rs.385 Cr; PAT surged 266% YoY to Rs.155 Cr, with all three lines benefiting from volume, pricing, and one-time gains.
  • Exports contributed 59% of Q1 FY 2026-2027 revenue; management expects export volumes to rise further in Q2 FY 2026-2027 while flagging quarter-on-quarter revenue recognition volatility from supply shifts to longer-voyage US destinations under DAP Incoterms.
  • Q1 FY 2026-2027 volumes declined 17% QoQ in energy, 7% QoQ in non-energy, and ~12% QoQ overall; management has stopped disclosing absolute volume numbers and will instead report energy/non-energy volume trends and utilization ranges by value chain.
  • Underlying EBITDA of ~Rs.300-310 Cr — an analyst estimated that stripping out the ~Rs.47 Cr forex benefit and ~Rs.50-60 Cr inventory gains leaves a base ~20% below the ~Rs.350 Cr quarterly run-rate management had previously telegraphed as consistent with the Rs.1,800 Cr FY 2026-2027 EBITDA target.

Capacity Expansion, Joint Ventures & Capital Allocation

  • CAPEX guided at Rs.700-800 Cr for FY 2026-2027, with Rs.180 Cr deployed in Q1; management expects CAPEX intensity to reduce from FY 2027-2028 onward as the Zone 4 build-out nears completion.
  • Fuel additives capacity expanded from 290 KTPA to 360 KTPA (brownfield, completed); DCB capacity debottlenecking to 140 KTPA is underway.
  • JV with Superform for amine derivatives on track for commissioning in Q2 FY 2026-2027; Aarti Circularity (plastic recycling) slated for commissioning in H2 FY 2026-2027.
  • Steady-state JV revenue guidance maintained at Rs.300-400 Cr, with meaningful PAT contribution expected within 2-4 quarters (i.e., by mid-FY 2027-2028) but initial visibility from Q2 FY 2026-2027.
  • Subsidiary planned in China to enhance sourcing and market presence; management sees future capex allocation driven by value addition, global cost competitiveness, scalability, and return on capital, with current focus on battery chemicals and defense applications.
  • Aarti Industries achieved EcoVadis Platinum rating, score 87/100, placing the company in the top 1% globally for sustainability performance.

MMA Diversification, Geopolitical Diversion & Demand Cycle

  • West Asia conflict reduced exports to the region from 15% to 2% of revenues in Q1 FY 2026-2027; management successfully diverted energy product flows to the US, Africa, Europe, and India, supported by market development and strong gasoline/naphtha cracks.
  • Gasoline-naphtha cracks averaged $15-18/barrel globally, back to pre-war levels per management, underpinning robust fuel-additive demand; the MMA/fuel additives market was described as “pretty strong” as of Q1 FY 2026-2027.
  • Management is expanding the fuel additives portfolio beyond MMA with 3-5 products in development; scale-up expected over the next 12 months (through FY 2026-2027 into FY 2027-2028).
  • Brownfield capacity for the overall fuel additives block reached 360 KT (not MMA-specific); management aims to stabilize that capacity over the next 12 months and expects to reach high utilization levels in Q2 FY 2026-2027.
  • Winter season (end-October to December) typically weakens MMA demand, though current traction is strong; management is evaluating mitigation strategies for volume placements during the lean season.

EBITDA Trajectory, Forex, Inventory & Underlying Earnings

  • Q1 FY 2026-2027 EBITDA of Rs.385 Cr included ~Rs.47 Cr forex benefit and an estimated ~Rs.50-60 Cr of inventory gains; CFO Chemtan Gandhi explained forex gains arose from rupee volatility in the 92-97 range and recommended treating them as part of operating profit given their link to imported inventory.
  • Management declined to provide a specific Q2 FY 2026-2027 EBITDA run-rate forecast, citing monthly price corrections of ±15-20% and that Q1 gains may not repeat but could be offset by volume growth.
  • The reported ~16% EBITDA margin in Q1 FY 2026-2027 is not assured to be maintained; volume growth is expected for FY 2026-2027, but pricing, margins, and inventory costs depend on the West Asia geopolitical situation and the pace of raw-material price changes.
  • Gross margin declined sequentially due to within-quarter factors (timing of raw-material purchases, product mix, forex, freight, lower volumes) and is not reflective of steady-state performance, per management.
  • Management hedges inventory risk via fast domestic pass-through (inventory of 7-15 days) and forward booking for imported materials (inventory of 1-1.5 months), mitigating crude-linked raw-material volatility.

Commissioning Delays, Chemistry Blocks & Product Pipeline

  • Zone 4 commissioning delayed by at least 6 months for 5 chemistry blocks due to labor shortages (LPG issue, elections, monsoon), not market conditions; 97% of equipment erected, 85% of piping complete; management expects commissioning within FY 2026-2027.
  • Despite the delay, FY 2027-2028 (FY28) guidance remains intact; JVs (OAG and RSL), the NPP, multipurpose plant, and calcium chloride unit in Zone 4 are expected to commission on track.
  • Multi-purpose plant first product expected in August 2026 (Q2 FY 2026-2027); management targets 5-10 products in FY 2026-2027, scaling to 25-30 products by end of FY 2027-2028.
  • Product mix diversified across agro, pharma, coatings, and polymers, avoiding concentration in one end-market; management changed Zone 4 strategy ~1.5 years ago to make the chain capable of multiple chemistries beyond chlorotoluene.
  • Competition already exists with 2-3 players in India and China; management expressed confidence in maintaining cost leadership and market leadership through differentiation, global supply chain optimization, and distribution strategy.

Guidance, Demand Recovery & Macro Risks

  • FY 2026-2027 EBITDA guidance of Rs.1,800 Cr includes the Aurigene JV; the RT JV is not expected to contribute meaningfully before FY 2027-2028, and the reporting treatment for JV EBITDA is yet to be decided.
  • Demand recovery for polymers and agrochemicals expected in Q2 FY 2026-2027; non-energy volume softness in Q1 was attributed to supply-chain issues and delayed purchasing in a high-price environment, not Middle East disruption.
  • Global majors (ExxonMobil, South Korean companies) have retired 10-15 million tons of ethylene/naphtha capacity over the past 12 months; management cited this rationalization, along with slowing expansion in China, as a potential basis for fundamental restructuring of the chemical industry margin profile post FY28-29, calling it a “personal hypothesis” requiring 2-3 more years to materialize.
  • For ethylated products (e.g., OEA, 26 NEA), most contracts have pass-through pricing for ethylene, securing the margin profile per CEO Suog Kotecha; however, the products are not produced in Japan, South Korea, or Thailand, so the cracker closures in those regions do not present a direct opportunity for Aarti Industries.
  • Pricing, margins, and inventory costs remain contingent on the West Asia geopolitical situation; management expressed confidence in volume growth for FY 2026-2027 but remains cautious on margins due to macro uncertainty, with ~16% Q1 margin not assured to be maintained.

Ask about this

Ask Cofacto a question about this call. Answers cite filings and company data.

Companies on this page

Related

Share on X · LinkedIn · WhatsApp

Disclaimer: This earnings call summary is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.